USD10
PHAT Shares
About Phathom PharmaceuticalsPhathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

USD10
PHAT Shares
About Phathom PharmaceuticalsPhathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Stats

TRADING WINDOW

Closed

OPENS AT

Not enough data

MARKET CAP

$872.53M

OPEN PRICE

$10.86

LOW (1Y)

$7.61

HIGH (1Y)

$18.31

LOW (24H)

$10.86

HIGH (24H)

$11.33

VOLUME (24H)

$480.19K

9.66%

Price history

Time
Price
Change
Today
$10.86
0.74%
1 Day
$10.95
0.09%
1 Week
$12.62
13.31%
1 Month
$10.91
0.27%
1 Year
$7.83
39.72%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.